IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Journal of Experimental and Clinical Medicine
  • Volume:40 Issue:4
  • ORPHAN DRUGS: REVIEW ARTICLE

ORPHAN DRUGS: REVIEW ARTICLE

Authors : Hilal Aksoy
Pages : 792-794
View : 140 | Download : 102
Publication Date : 2024-01-03
Article Type : Review Paper
Abstract :Drugs which have limited access and are used treat rare diseases, are called \"orphan drugs\". The reason why these drugs are called \"orphan\" is that the pharmaceutical industry has little interest in developing and marketing these drugs which are used only for a low number of patient groups This is because pharmaceutical companies cannot compensate the very high cost of developing these drugs. In this review article it is aimed to give information about orphan drugs, policies about these drugs and difficulties to reach them.
Keywords : orphan drugs, rare diseases, pharmaceutic, marketing

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026